President Trump said Monday that he has been taking the antimalarial drug hydroxychloroquine for the last “couple of weeks” as a preventive against the coronavirus.
“I’m taking it, hydroxychloroquine, right now, yeah,” Trump told reporters at the White House. “Couple of weeks ago, I started taking it. Because I think it’s good, I hear a lot of good stories. And if it’s not good, I’ll tell you right. I’m not going to get hurt by it.”
According to the White House, Trump is tested every day for the coronavirus and at last report had not been infected.
Hydroxychloroquine, taken together with the antibiotic azithromycin, appeared to show promising results in a limited, non-peer-reviewed study conducted in France on patients hospitalized with COVID-19. But subsequent trials showed that the drug offered no benefits to patients, and posed potentially serious health risks.
No studies have been published on taking hydroxychloroquine to prevent infection.
Hours after Trump announced he was taking the drug, his physician, Sean P. Conley, released a statement in which he said that he and the president had spoken about taking the drug.
“After numerous discussions he and I had regarding the evidence for and against hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks,” Conley said in the statement without specifying what evidence of a “potential benefit” he had relied upon to reach that conclusion.
Trump also said he is not receiving azithromycin, but is taking supplements of zinc, believed by some to boost the immune system.
“I want the people of this nation to feel good,” Trump said of his decision to use hydroxychloroquine despite having tested negative for COVID-19. He added, “I’ve taken it for about a week and a half now, and I’m still here.”
- Damon Nam is Disrupting the Blockchain Industry with Emerging FinTech Company, Coin. - November 6, 2020
- Meet Entrepreneur Quinelle Holder, THe Founder of Medium Creative Agency - September 30, 2020
- Thomas Auringer: Building Buildings and Building Cultures - September 23, 2020